History of cholelithiasis and cancer risk in a network of case-control studies

Annals of Oncology

Volumn 23, Issue 8, 2012, Pages 2173-2178

  Tavani, A ^a   Rosato, V ^a   Di Palma, F ^a   Bosetti, C ^a   Talamini, R ^b   Dal Maso, L ^b,c   Zucchetto, A ^b   Levi, F ^d   Montella, M ^e   Negri, E ^a   Franceschi, S ^f   La Vecchia, C ^a,c,g  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Case control study; Cholelithiasis; Kidney cancer; Prostate cancer; Small intestinal cancer

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHOLELITHIASIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; HUMAN; ITALY; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SMALL INTESTINE CANCER; STOMACH CANCER; SWITZERLAND;

EID: 84864956098     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr581     Document Type: Article

References (59)

1. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 1994; 3: 205-207.
2. Johansen C, Chow WH, Jorgensen T et al. Risk of colorectal cancer and other cancers in patients with gall stones. Gut 1996; 39: 439-443.
3. Zatonski WA, Lowenfels AB, Boyle p et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997; 89(15): 1132-1138.
4. Kaerlev L, Teglbjaerg PS, Sabroe S et al. Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European population-based casecontrol study. Scand J Gastroenterol 2001; 36: 641-646.
5. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis?. Gastroenterology 2001; 121: 542-547.
6. Anderson KE, Mack TM, Silverman DT. Pancreatic cancer. In Schottenfeld D, Fraumeni JF, Jr, Cancer Epidemiology and Prevention, 3rd edition. New York: Oxford University Press 2006; 721-762.
7. Giovannucci E, Wu K. Schottenfeld D, Fraumeni JF, Jr. Cancers of the colon and rectum. Cancer Epidemiology and Prevention 3rd edition. New York: Oxford University Press 2006; 809-829.
8. Hsing AW, Rashid A, Devesa SS, Fraumeni JF, Jr. Biliary tract cancer. In Schottenfeld D, Fraumeni JF, Jr, Cancer Epidemiology and Prevention, 3rd edition. New York: Oxford University Press 2006; 787-800.
9. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-1602.
10. Lagergren J, Mattsson F. Cholecystectomy and risk of laryngeal and pharyngeal cancer. Int J Cancer 2011 June 29 [epub ahead of print].
11. Goldacre MJ, Abisgold JD, Seagroatt V, Yeates D. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer 2005; 92: 1307-1309.
12. Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011; 140: 508-516.
13. Garavello W, Foschi R, Talamini R et al. Family history and the risk of oral and pharyngeal cancer. Int J Cancer 2008; 122: 1827-1831.
14. Levi F, Pasche C, La Vecchia C et al. Food groups and risk of oral and pharyngeal cancer. Int J Cancer 1998; 77: 705-709.
15. D'Avanzo B, La Vecchia C, Talamini R, Franceschi S. Anthropometric measures and risk of cancers of the upper digestive and respiratory tract. Nutr Cancer 1996; 26: 219-227.
16. Bosetti C, La Vecchia C, Talamini R et al. Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer 2000; 87: 289-294.
17. Levi F, Pasche C, Lucchini F et al. Food groups and oesophageal cancer risk in Vaud, Switzerland. Eur J Cancer Prev 2000; 9: 257-263.
18. La Vecchia C, D'Avanzo B, Negri E et al. Attributable risks for stomach cancer in northern Italy. Int J Cancer 1995; 60: 748-752.
19. Lucenteforte E, Scita V, Bosetti C et al. Food groups and alcoholic beverages and the risk of stomach cancer: a case-control study in Italy. Nutr Cancer 2008; 60: 577-584.
20. Negri E, Bosetti C, La Vecchia C et al. Risk factors for adenocarcinoma of the small intestine. Int J Cancer 1999; 82: 171-174.
21. La Vecchia C, D'Avanzo B, Negri E, Franceschi S. History of selected diseases and the risk of colorectal cancer. Eur J Cancer 1991; 27: 582-586.
22. Negri E, Bosetti C, La Vecchia C et al. Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer 1999; 35: 1838-1841.
23. Altieri A, Pelucchi C, Talamini R et al. Cholecystectomy and the risk of colorectal cancer in Italy. Br J Cancer 2004; 90: 1753-1755.
24. La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998; 7: 315-320.
25. Polesel J, Zucchetto A, Montella M et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009; 20: 353-357.
26. Lipworth L, Zucchetto A, Bosetti C et al. Diabetes mellitus, other medical conditions and pancreatic cancer: a case-control study. Diabetes Metab Res Rev 2011; 27: 255-261.
27. Bosetti C, La Vecchia C, Talamini R et al. Food groups and laryngeal cancer risk: a case-control study from Italy and Switzerland. Int J Cancer 2002; 100: 355-360.
28. Franceschi S, la Vecchia C, Negri E et al. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26: 781-785.
29. Talamini R, Franceschi S, Favero A et al. Selected medical conditions and risk of breast cancer. Br J Cancer 1997; 75: 1699-1703.
30. Lucenteforte E, Bosetti C, Talamini R et al. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br J Cancer 2007; 97: 995-998.
31. Parazzini F, Moroni S, La Vecchia C et al. Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1997; 33: 1634-1637.
32. Tavani A, Gallus S, La Vecchia C et al. Aspirin and ovarian cancer: an Italian case-control study. Ann Oncol 2000; 11: 1171-1173.
33. Talamini R, Franceschi S, Dal Bo V, Monfardini S. Pattern and determinants of diagnostic interval in cancers of the prostate, bladder and kidney. Tumori 1991; 77: 350-354.
34. Bravi F, Scotti L, Bosetti C et al. Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer. Ann Oncol 2006; 17: 1014-1017.
35. Zucchetto A, Dal Maso L, Tavani A et al. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Ann Oncol 2007; 18: 596-600.
36. Breslow NE, Day NE. The analysis of case-control studies. In Statistical Methods in Cancer Research, Vol. 1, Lyon, France: IARC Science Publications 1980.
37. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
38. Ross RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?. Br J Cancer 1991; 63: 143-145.
39. Lowenfels AB. Gallstones and the risk of cancer. Gut 1980; 21: 1090-1092.
40. Li Q, Kuriyama S, Kakizaki M et al. History of cholelithiasis and the risk of prostate cancer: the Ohsaki Cohort Study. Int J Cancer 2011; 128: 185-191.
41. Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem 2004; 91: 54-69.
42. Cyrus-David MS, Weinberg A, Thompson T, Kadmon D. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. J Urol 2005; 173: 1923-1925.
43. Moyad MA, Merrick GS, Butler WM et al. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer. Urology 2005; 66: 1150-1154.
44. Shannon J, Tewoderos S, Garzotto M et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol 2005; 162: 318-325.
45. Bergstrom A, Hsieh CC, Lindblad P et al. Obesity and renal cell cancer-a quantitative review. Br J Cancer 2001; 85: 984-990.
46. Dal Maso L, Zucchetto A, Tavani A et al. Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol 2007; 166: 582-591.
47. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993; 105: 130-141.
48. Reid FD, Mercer PM, Harrison M, Bates T. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol 1996; 31: 160-169.
49. Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005; 100: 1813-1820.
50. Lin HL, Lin HC, Lin CC. Increased risk of colorectal cancer among patients with biliary tract inflammation: a 5-year follow-up study. Int J Cancer 2011; 128: 447-452.
51. Ko AH, Wang F, Holly EA. Pancreatic cancer and medical history in a populationbased case-control study in the San Francisco Bay Area, California. Cancer Causes Control 2007; 18: 809-819.
52. Freedman J, Lagergren J, Bergstrom R et al. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg 2000; 87: 1087-1093.
53. Freedman J, Ye W, Naslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology 2001; 121: 548-553.
54. Fall K, Ye W, Nyren O. Risk for gastric cancer after cholecystectomy. Am J Gastroenterol 2007; 102: 1180-1184.
55. Adami HO, Meirik O, Gustavsson S et al. Cholecystectomy and the incidence of breast cancer: a cohort study. Br J Cancer 1984; 49: 235-239.
56. Lagergren J, Ye W, Ekbom A. No increased risk of breast cancer after cholecystectomy. Int J Cancer 2000; 88: 679-681.
57. Shibata A, Ogimoto I, Kurozawa Y et al. Past medical history and risk of death due to hepatocellular carcinoma, univariate analysis of JACC study data. Kurume Med J 2003; 50: 109-119.
58. Morimoto LM, Newcomb PA, Hampton JM, Trentham-Dietz A. Cholecystectomy and endometrial cancer: a marker of long-term elevated estrogen exposure?. Int J Gynecol Cancer 2006; 16: 1348-1353.
59. Bosetti C, Tavani A, Negri E et al. Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol 2001; 54: 902-906.